The WACC of NextCell Pharma AB (NXTCL.ST) is 6.2%.
| Range | Selected | |
| Cost of equity | 5.60% - 8.00% | 6.80% |
| Tax rate | 20.60% - 20.90% | 20.75% |
| Cost of debt | 7.00% - 7.00% | 7.00% |
| WACC | 5.6% - 6.8% | 6.2% |
| Category | Low | High |
| Long-term bond rate | 2.5% | 3.0% |
| Equity market risk premium | 5.1% | 6.1% |
| Adjusted beta | 0.61 | 0.73 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 5.60% | 8.00% |
| Tax rate | 20.60% | 20.90% |
| Debt/Equity ratio | 1 | 1 |
| Cost of debt | 7.00% | 7.00% |
| After-tax WACC | 5.6% | 6.8% |
| Selected WACC | 6.2% | |